Evoke Pharma
EVOK
EVOK
21 hedge funds and large institutions have $5.46M invested in Evoke Pharma in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.01% less ownership
Funds ownership: 0.1% → 0.09% (-0.01%)
11% less capital invested
Capital invested by funds: $6.17M → $5.46M (-$706K)
Holders
21
Holding in Top 10
–
Calls
$329K
Puts
$4K
Top Buyers
| 1 | +$95K | |
| 2 | +$50.1K | |
| 3 | +$45.1K | |
| 4 |
VF
Virtu Financial
New York
|
+$25K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$21K |
Top Sellers
| 1 | -$612K | |
| 2 | -$19.5K | |
| 3 | -$13.8K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$7.2K |
| 5 |
Citigroup
New York
|
-$1K |